Connected infusion therapy devices for hospital, ambulatory, and home care
Eitan Medical manufactures infusion delivery systems spanning hospital to home settings. The tech stack reveals embedded-first engineering: C/C++, FreeRTOS, Zephyr, ThreadX, plus wireless protocols (BLE, Wi-Fi) and cloud integration (Azure, Salesforce), indicating real-time device connectivity and remote monitoring capabilities. Current hiring prioritizes healthcare domain expertise and manufacturing scale (healthcare and manufacturing roles outnumber engineering openings 7:2), while projects around Salesforce implementation and French market growth signal a sales and geographic expansion phase.
Eitan Medical designs and manufactures infusion therapy devices for clinical and home settings. The product line spans hospital-based systems, ambulatory care solutions, and home infusion platforms — each engineered for safety, ease of use, and connectivity. The company serves hospitals, clinics, and home healthcare providers with devices designed for both patient and clinician workflows. Operations span the United States, Canada, and Israel, with current initiatives focused on commercial scaling in Europe and improving clinician training on newer product generations.
Eitan Medical uses embedded C/C++ with FreeRTOS and Zephyr operating systems, plus wireless protocols like Bluetooth Low Energy and Wi-Fi. Backend systems run on Azure, PostgreSQL, and Elasticsearch; frontend interfaces use React, Vue, and Angular.
Eitan Medical is headquartered in Aliso Viejo, California, with operations spanning the United States, Canada, and Israel.
Other companies in the same industry, closest in size
Eitan Medical's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.